Complete miscarriage · early fetal death (less than 24 weeks)
Vaginal misoprostol may leads to higher complete miscarriage compared with placebo (low certainty).
1 finding from 1 review
Pelvic infection · early fetal death (less than 24 weeks)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nausea · early fetal death (less than 24 weeks)
Vaginal misoprostol showed no clear difference in nausea compared with placebo (low certainty).
1 finding from 1 review
Diarrhoea · early fetal death (less than 24 weeks)
Vaginal misoprostol showed no clear difference in diarrhoea compared with placebo (low certainty).
1 finding from 1 review
Blood loss: haemoglobin difference > 10 g/L · early fetal death (less than 24 weeks)
It is very uncertain whether vaginal misoprostol changes blood loss: haemoglobin difference > 10 g/L compared with placebo (very low certainty).
1 finding from 1 review
Opiate use (as a proxy measure for pain) for all participants on ITT (including those without confirmed AMI) · early fetal death (less than 24 weeks)
It is very uncertain whether vaginal misoprostol changes pain (opiate use) compared with placebo (very low certainty).
1 finding from 1 review
Woman’s satisfaction/acceptability of method · early fetal death (less than 24 weeks)
Vaginal misoprostol showed no clear difference in woman’s satisfaction/acceptability of method compared with placebo (low certainty).
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · women requiring induction of labour
1 finding from 1 review
Vaginal birth not achieved in 48 to 72 h · women requiring induction of labour
1 finding from 1 review
Uterine hyperstimulation with fetal heart rate changes · women requiring induction of labour
Vaginal misoprostol showed no clear difference in uterine hyperstimulation (with fetal heart rate changes) compared with placebo (low certainty).
1 finding from 1 review
Caesarean section · women requiring induction of labour
Vaginal misoprostol showed no clear difference in caesarean section compared with placebo (low certainty).
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · women requiring induction of labour
Vaginal misoprostol showed no clear difference in serious neonatal morbidity or death compared with placebo (low certainty).
1 finding from 1 review
Serious maternal morbidity or death · women requiring induction of labour
1 finding from 1 review
Admission to neonatal intensive care unit · women requiring induction of labour
Vaginal misoprostol showed no clear difference in neonatal intensive care unit admission compared with placebo (low certainty).
1 finding from 1 review